Genzyme Plant Hits Production Setback - Wall Street Journal
Genzyme Plant Hits Production SetbackWall Street JournalGenzyme Corp. encountered a production setback for rare-disease drug Fabrazyme at its troubled Allston, Mass., plant that will lead to further treatment disruption for some Fabry's disease patients. The problem arose in the final stage ...Genzyme drug sees new supply disruptionBoston GlobeGenzyme Fabrazyme shortage to worsenBizjournals.comThe TickerBoston HeraldMass High Tech�-Seeking Alpha�-FiercePharmaall 16 news articles��
Blog Content
No comments:
Post a Comment